{
    "medicine_id": "c9729113b1eef86ac5f5580882cdb32d4ce162f0",
    "platform_id": "DB15965",
    "metadata": {
        "name": "Swical Extra fort Tablet",
        "composition": "Naxitamab",
        "clinical_particulars": {
            "therapeutic_indications": "Naxitamab gqgk is indicated in combination with granulocyte macrophage colony stimulating factor GM CSF for the treatment of patients 1 year of age and older with relapsed or refractory high risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response minor response or stable disease to prior therapy L24454",
            "contraindications": {
                "disease": "Data regarding overdose of naxitamab are unavailable In the event of an overdose patients should be treated with symptomatic and supportive measures",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "In targeting cell surface glycoproteins GD2 that occur on the surface of neuroendocrine tumors naxitamab directs the immune system towards these cancerous cells and induces the activation of both complement dependent and antibody dependent cytotoxicity L24454 Naxitamab can cause serious infusion reactions including hypotension hypoxia anaphylaxis and cardiac arrest that necessitate careful monitoring during therapy All patients should be pre medicated with intravenous corticosteroids e g methylprednisolone as well as an antihistamine H2 receptor antagonist acetaminophen and an antiemetic prior to therapy to mitigate the risk and severity of infusion related reactions Naxitamab may also cause severe neurotoxicity including significant neuropathic pain transverse myelitis reversible posterior leukoencephalopathy syndrome RPLS and ocular toxicities Pain management should be implemented prior to and during therapy patients should take a 12 day course of neuropathic pain prophylaxis e g gabapentin starting 4 days prior to infusion and should receive oral opioids 45 60 minutes prior to infusion and intravenous opioids and or ketamine as needed thereafter L24454",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00177",
                        "description": "Naxitamab may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Naxitamab may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Naxitamab may decrease the antihypertensive activities of Esmolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Naxitamab may decrease the antihypertensive activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Naxitamab may decrease the antihypertensive activities of Reserpine"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Naxitamab may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Naxitamab may decrease the antihypertensive activities of Torasemide"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Naxitamab may decrease the antihypertensive activities of Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Naxitamab may decrease the antihypertensive activities of Isradipine"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Naxitamab may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Naxitamab may decrease the antihypertensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Naxitamab may decrease the antihypertensive activities of Atenolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Naxitamab may decrease the antihypertensive activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Naxitamab may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Naxitamab may decrease the antihypertensive activities of Timolol"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Naxitamab may decrease the antihypertensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Naxitamab may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Naxitamab may decrease the antihypertensive activities of Prazosin"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Naxitamab may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Naxitamab may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Naxitamab may decrease the antihypertensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Naxitamab may decrease the antihypertensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Naxitamab may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Naxitamab may decrease the antihypertensive activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "Naxitamab may decrease the antihypertensive activities of Clonidine"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Naxitamab may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Naxitamab may decrease the antihypertensive activities of Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Naxitamab may decrease the antihypertensive activities of Labetalol"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Naxitamab may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Naxitamab may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Naxitamab may decrease the antihypertensive activities of Losartan"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Naxitamab may decrease the antihypertensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Naxitamab may decrease the antihypertensive activities of Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Naxitamab may decrease the antihypertensive activities of Furosemide"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Naxitamab may decrease the antihypertensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Naxitamab may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Naxitamab may decrease the antihypertensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Naxitamab may decrease the antihypertensive activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Naxitamab may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Naxitamab may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "Naxitamab may decrease the antihypertensive activities of Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Naxitamab may decrease the antihypertensive activities of Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Naxitamab may decrease the antihypertensive activities of Indapamide"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Naxitamab may decrease the antihypertensive activities of Tadalafil"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Naxitamab may decrease the antihypertensive activities of Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Naxitamab may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Naxitamab may decrease the antihypertensive activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Naxitamab may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "Naxitamab may decrease the antihypertensive activities of Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "Naxitamab may decrease the antihypertensive activities of Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Naxitamab may decrease the antihypertensive activities of Pindolol"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Naxitamab may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Naxitamab may decrease the antihypertensive activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Naxitamab may decrease the antihypertensive activities of Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Naxitamab may decrease the antihypertensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Naxitamab may decrease the antihypertensive activities of Felodipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Naxitamab may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Naxitamab may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Naxitamab may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Naxitamab may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Naxitamab may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Naxitamab may decrease the antihypertensive activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Naxitamab may decrease the antihypertensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "Naxitamab may decrease the antihypertensive activities of Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Naxitamab may decrease the antihypertensive activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Naxitamab may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Naxitamab may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Naxitamab may decrease the antihypertensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Naxitamab may decrease the antihypertensive activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Naxitamab may decrease the antihypertensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Naxitamab may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Naxitamab may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Naxitamab may decrease the antihypertensive activities of Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Naxitamab may decrease the antihypertensive activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Naxitamab may decrease the antihypertensive activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Naxitamab may decrease the antihypertensive activities of Pargyline"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Naxitamab may decrease the antihypertensive activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Naxitamab may decrease the antihypertensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Naxitamab may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Naxitamab may decrease the antihypertensive activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "Naxitamab may decrease the antihypertensive activities of Lofexidine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Naxitamab may decrease the antihypertensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Naxitamab may decrease the antihypertensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Naxitamab may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Naxitamab may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Naxitamab may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Naxitamab may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Naxitamab may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Naxitamab may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "Naxitamab may decrease the antihypertensive activities of Indoramin"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Naxitamab may decrease the antihypertensive activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Naxitamab may decrease the antihypertensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Naxitamab may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Naxitamab may decrease the antihypertensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Naxitamab may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Naxitamab may decrease the antihypertensive activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Naxitamab may decrease the antihypertensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Naxitamab may decrease the antihypertensive activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Naxitamab may decrease the antihypertensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "Naxitamab may decrease the antihypertensive activities of Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Naxitamab may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Naxitamab may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Naxitamab may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Naxitamab may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Naxitamab may decrease the antihypertensive activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Naxitamab may decrease the antihypertensive activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Naxitamab may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Naxitamab may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Naxitamab may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Naxitamab may decrease the antihypertensive activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Naxitamab may decrease the antihypertensive activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Naxitamab may decrease the antihypertensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Naxitamab may decrease the antihypertensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Naxitamab may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Naxitamab may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Naxitamab may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Naxitamab may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Naxitamab may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Naxitamab may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Naxitamab may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Naxitamab may decrease the antihypertensive activities of Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Naxitamab may decrease the antihypertensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Naxitamab may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Naxitamab may decrease the antihypertensive activities of Epanolol"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Naxitamab may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Naxitamab may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Naxitamab may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Naxitamab may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Naxitamab may decrease the antihypertensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Naxitamab may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Naxitamab may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Naxitamab may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Naxitamab may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Naxitamab may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Naxitamab may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Naxitamab may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of hypertension can be increased when Cyclosporine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of hypertension can be increased when Amphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of hypertension can be increased when Phentermine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of hypertension can be increased when Midodrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of hypertension can be increased when Eletriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of hypertension can be increased when Isoetharine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of hypertension can be increased when Ziprasidone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of hypertension can be increased when Methysergide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of hypertension can be increased when Cabergoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of hypertension can be increased when Atomoxetine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of hypertension can be increased when Etomidate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of hypertension can be increased when Zolmitriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of hypertension can be increased when Amitriptyline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of hypertension can be increased when Indomethacin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of hypertension can be increased when Protriptyline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The risk or severity of hypertension can be increased when Methylergometrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of hypertension can be increased when Clozapine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of hypertension can be increased when Norepinephrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of hypertension can be increased when Mirtazapine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypertension can be increased when Phenylephrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of hypertension can be increased when Promazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of hypertension can be increased when Methylphenidate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of hypertension can be increased when Droperidol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of hypertension can be increased when Imipramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of hypertension can be increased when Nabumetone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Ketorolac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of hypertension can be increased when Tenoxicam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of hypertension can be increased when Chlorpromazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of hypertension can be increased when Celecoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of hypertension can be increased when Buspirone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Tolmetin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of hypertension can be increased when Rofecoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of hypertension can be increased when Nortriptyline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of hypertension can be increased when Amoxapine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of hypertension can be increased when Piroxicam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of hypertension can be increased when Atropine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Fenoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of hypertension can be increased when Valdecoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of hypertension can be increased when Diclofenac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of hypertension can be increased when Lisuride is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of hypertension can be increased when Linezolid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Sulindac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of hypertension can be increased when Metaraminol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of hypertension can be increased when Furazolidone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of hypertension can be increased when Dexmedetomidine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of hypertension can be increased when Trazodone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of hypertension can be increased when Epinephrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of hypertension can be increased when Sumatriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of hypertension can be increased when Thioridazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of hypertension can be increased when Ergotamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The risk or severity of hypertension can be increased when Nicergoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of hypertension can be increased when Sufentanil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of hypertension can be increased when Flurbiprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of hypertension can be increased when Methoxamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of hypertension can be increased when Trimipramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of hypertension can be increased when Risperidone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of hypertension can be increased when Etodolac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of hypertension can be increased when Tranylcypromine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of hypertension can be increased when Isoflurane is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of hypertension can be increased when Propiomazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of hypertension can be increased when Phenelzine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of hypertension can be increased when Mefenamic acid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of hypertension can be increased when Naproxen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of hypertension can be increased when Sulfasalazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of hypertension can be increased when Alfentanil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of hypertension can be increased when Minaprine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of hypertension can be increased when Phenylbutazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of hypertension can be increased when Fentanyl is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of hypertension can be increased when Meloxicam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of hypertension can be increased when Orciprenaline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of hypertension can be increased when Propofol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Carprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of hypertension can be increased when Trifluoperazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of hypertension can be increased when Dobutamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Diflunisal is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of hypertension can be increased when Benzphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of hypertension can be increased when Ritodrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of hypertension can be increased when Terbutaline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of hypertension can be increased when Flupentixol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of hypertension can be increased when Remifentanil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of hypertension can be increased when Bitolterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of hypertension can be increased when Quinidine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of hypertension can be increased when Almotriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypertension can be increased when Oxymetazoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of hypertension can be increased when Salicylic acid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of hypertension can be increased when Diethylpropion is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of hypertension can be increased when Salmeterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of hypertension can be increased when Naratriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of hypertension can be increased when Rizatriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of hypertension can be increased when Formoterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of hypertension can be increased when Dopamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Oxaprozin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of hypertension can be increased when Frovatriptan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of hypertension can be increased when Salbutamol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Ketoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Balsalazide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of hypertension can be increased when Methoxyflurane is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of hypertension can be increased when Selegiline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of hypertension can be increased when Ibuprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of hypertension can be increased when Isoprenaline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of hypertension can be increased when Arbutamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dutasteride is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of hypertension can be increased when Doxepin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hypertension can be increased when Nefazodone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of hypertension can be increased when Desipramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of hypertension can be increased when Halothane is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of hypertension can be increased when Moclobemide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of hypertension can be increased when Propafenone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of hypertension can be increased when Pergolide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of hypertension can be increased when Desflurane is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of hypertension can be increased when Bromocriptine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Finasteride is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of hypertension can be increased when Quetiapine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of hypertension can be increased when Sevoflurane is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of hypertension can be increased when Aripiprazole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of hypertension can be increased when Clomipramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of hypertension can be increased when Isocarboxazid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Olsalazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of hypertension can be increased when Ergometrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of hypertension can be increased when Paliperidone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of hypertension can be increased when Arformoterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of hypertension can be increased when Lumiracoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of hypertension can be increased when Fenoterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of hypertension can be increased when Pirbuterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of hypertension can be increased when Ephedrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of hypertension can be increased when Mephentermine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of hypertension can be increased when Procaterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of hypertension can be increased when Rasagiline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of hypertension can be increased when Yohimbine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Salsalate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of hypertension can be increased when Clenbuterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of hypertension can be increased when Bambuterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Antrafenine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of hypertension can be increased when Aminophenazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of hypertension can be increased when Antipyrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of hypertension can be increased when MMDA is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of hypertension can be increased when Midomafetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of hypertension can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of hypertension can be increased when 4 Methoxyamphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of hypertension can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of hypertension can be increased when Tenamfetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of hypertension can be increased when Chlorphentermine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of hypertension can be increased when Metamfetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of hypertension can be increased when Phendimetrazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of hypertension can be increased when Solifenacin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of hypertension can be increased when Periciazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of hypertension can be increased when Acepromazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of hypertension can be increased when Thioproperazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of hypertension can be increased when Etoricoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of hypertension can be increased when Clorgiline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypertension can be increased when Nimesulide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Benoxaprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of hypertension can be increased when Metamizole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of hypertension can be increased when Iproniazid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of hypertension can be increased when Nialamide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Zomepirac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of hypertension can be increased when Amineptine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of hypertension can be increased when Dronedarone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of hypertension can be increased when Flibanserin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of hypertension can be increased when Iloperidone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Cimicoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of hypertension can be increased when Rotigotine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of hypertension can be increased when Amibegron is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of hypertension can be increased when Naluzotan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of hypertension can be increased when Cariprazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of hypertension can be increased when Mianserin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypertension can be increased when Nylidrin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of hypertension can be increased when Pizotifen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of hypertension can be increased when Solabegron is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of hypertension can be increased when Asenapine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of hypertension can be increased when Droxidopa is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of hypertension can be increased when Safinamide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of hypertension can be increased when Esmirtazapine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of hypertension can be increased when Vilazodone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of hypertension can be increased when Nitrous oxide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypertension can be increased when Xylometazoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of hypertension can be increased when Isometheptene is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypertension can be increased when Levonordefrin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypertension can be increased when Naphazoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of hypertension can be increased when Lornoxicam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Aceclofenac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of hypertension can be increased when Zaltoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Saralasin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of hypertension can be increased when Tetryzoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Azapropazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of hypertension can be increased when Parecoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Salicylamide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of hypertension can be increased when Cinitapride is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of hypertension can be increased when Lurasidone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Tyramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of hypertension can be increased when Mirabegron is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of hypertension can be increased when Adrafinil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Kebuzone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of hypertension can be increased when Isoxsuprine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Isoxicam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Indoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of hypertension can be increased when Ifenprodil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Ibuproxam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of hypertension can be increased when Hexoprenaline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Floctafenine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Fenbufen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Etofenamate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of hypertension can be increased when Etilefrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Epirizole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of hypertension can be increased when Dimetacrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of hypertension can be increased when Butriptyline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of hypertension can be increased when Vortioxetine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of hypertension can be increased when Olodaterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Benzydamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of hypertension can be increased when Brexpiprazole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of hypertension can be increased when Dosulepin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypertension can be increased when Cirazoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of hypertension can be increased when Synephrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Moxisylyte is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Loxoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Dexibuprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Dexketoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Droxicam is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypertension can be increased when Tolfenamic acid is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Firocoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Clonixin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of hypertension can be increased when Methylene blue is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of hypertension can be increased when Hydracarbazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of hypertension can be increased when Pirlindole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of hypertension can be increased when Toloxatone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of hypertension can be increased when Benmoxin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of hypertension can be increased when Mebanazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of hypertension can be increased when Octamoxin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of hypertension can be increased when Pheniprazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of hypertension can be increased when Phenoxypropazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of hypertension can be increased when Pivhydrazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of hypertension can be increased when Safrazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of hypertension can be increased when Caroxazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of hypertension can be increased when Doxofylline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Morniflumate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of hypertension can be increased when Propacetamol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of hypertension can be increased when Tianeptine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Talniflumate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of hypertension can be increased when Oxaprotiline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of hypertension can be increased when Iofetamine I 123 is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of hypertension can be increased when Racepinephrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocornine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of hypertension can be increased when DL Methylephedrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of hypertension can be increased when Amitraz is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of hypertension can be increased when Medetomidine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Robenacoxib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Tepoxalin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of hypertension can be increased when Xylazine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Atipamezole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Flunixin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of hypertension can be increased when Ractopamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of hypertension can be increased when Romifidine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of hypertension can be increased when Detomidine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of hypertension can be increased when Etafedrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of hypertension can be increased when Tetrahydrocannabivarin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of hypertension can be increased when Anisodamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of hypertension can be increased when PF 00610355 is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of hypertension can be increased when Ritobegron is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of hypertension can be increased when Abediterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of hypertension can be increased when Tulobuterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of hypertension can be increased when Propiverine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of hypertension can be increased when Dopexamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of hypertension can be increased when Piclozotan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of hypertension can be increased when Siponimod is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Nitroaspirin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Indobufen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Idazoxan is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Ebselen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of hypertension can be increased when Higenamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of hypertension can be increased when Reproterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of hypertension can be increased when Theodrenaline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of hypertension can be increased when Opipramol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Tinoridine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Tramazoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of hypertension can be increased when Mephedrone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of hypertension can be increased when Levosalbutamol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Alclofenac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Fentiazac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of hypertension can be increased when Dibenzepin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Suxibuzone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of hypertension can be increased when Quinupramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypertension can be increased when Octopamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Bumadizone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Alminoprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of hypertension can be increased when Trichloroethylene is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Fenozolone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Difenpiramide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of hypertension can be increased when Norfenefrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of hypertension can be increased when Melitracen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocryptine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of hypertension can be increased when Oxyfedrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "The risk or severity of hypertension can be increased when Terguride is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Nifenazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of hypertension can be increased when Lofepramine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Lonazolac is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Xenon is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Tenidap is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of hypertension can be increased when Iprindole is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Buflomedil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of hypertension can be increased when Metergoline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Propyphenazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Proglumetacin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Guacetisal is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Ethenzamide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of hypertension can be increased when Rimiterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of hypertension can be increased when Diethyl ether is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Carbaspirin calcium is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of hypertension can be increased when Methoxyphenamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Mofebutazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Proquazone is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Benorilate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of hypertension can be increased when Tretoquinol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of hypertension can be increased when Gepefrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Pirprofen is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of hypertension can be increased when Prenalterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of hypertension can be increased when Xamoterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of hypertension can be increased when Imipramine oxide is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Acemetacin is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Mefenorex is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Imidazole salicylate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of hypertension can be increased when Harmaline is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of hypertension can be increased when Deoxyepinephrine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of hypertension can be increased when 2 5 Dimethoxy 4 ethylthioamphetamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of hypertension can be increased when 5 methoxy N N dimethyltryptamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when SC 236 is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when NS 398 is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of hypertension can be increased when Aripiprazole lauroxil is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Quinoline Yellow WS is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Selpercatinib is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "Succinylcholine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00260",
                        "description": "Cycloserine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "Vinorelbine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Sulpiride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "Loxapine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "Remoxipride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "Prochlorperazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Teniposide may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Haloperidol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "Cyclophosphamide may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Vincristine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Fluphenazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "Stavudine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Perphenazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "Cyclobenzaprine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "Mesoridazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Acetophenazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "Pimozide may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "Clindamycin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "Paclitaxel may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Chlorprothixene may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Alimemazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "Imipenem may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "Aceprometazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "Molindone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Pipotiazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "Thiothixene may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "Lincomycin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Fluspirilene may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "Osanetant may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "Bifeprunox may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "Pimavanserin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "BL 1020 may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "Sertindole may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "Amisulpride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "Viomycin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "Perospirone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "Amperozide may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Cyamemazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "Sodium citrate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Blonanserin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Melperone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "Zotepine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "Brilaroxazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09275",
                        "description": "Bismuth subcitrate potassium may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "Pipamperone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11281",
                        "description": "Bismuth subcarbonate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "Azaperone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "Pirlimycin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Propiopromazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "Ecopipam may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "Bromperidol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "Raclopride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "Ritanserin may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Perazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "Benperidol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "Prothipendyl may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Tiapride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "Bismuth subnitrate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Butaperazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "Clothiapine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "Sultopride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Chlorproethazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "Oxypertine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Thiazinam may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "Veralipride may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "Trifluperidol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "Moperone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "Thiopropazate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "Gallamine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "Fluanisone may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "Mosapramine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Dixyrazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Penfluridol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "Clopenthixol may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Bismuth subgallate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "Valproate bismuth may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Perphenazine enanthate may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00781",
                        "description": "Polymyxin B may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Naxitamab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}